CAS No. |
1626359-59-8 |
中文名称 |
输入的IUPAC名称不完整,无法进行准确、无歧义的标准中文命名 |
英文名称 |
4-((5-(((S)-1-(((14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl)oxy)-1-oxopropan-2-yl)(methyl)amino)-2-methyl |
别名 |
sulfo-SPDB-DM4;Maytansine, N2'-deacetyl-N2'-[4-[[4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxo-3-sulfobutyl]dithio]-4-methyl-1-oxopentyl]-;4-((5-(((S)-1-(((14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl)oxy)-1-oxopropan-2-yl)(methyl)amino)-2-methyl-5-oxopentan-2-yl)disulfanyl)-1-((2,5-dioxopyrrolidin-1-yl)oxy)-1-oxobutane-2-sulfonic acid |
标准英文名 |
4-((5-(((S)-1-(((14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl)oxy)-1-oxopropan-2-yl)(methyl)amino)-2-methyl-5-oxopentan-2-yl)disulfaneyl)-1-((2,5-dioxopyrrolidin-1-yl)oxy)-1-oxobutane-2-sulfonic acid |
分子式 |
C46H63ClN4O17S3 |
分子量 |
1075.68
|
精确分子量 |
1074.30
|
SMILES |
COC1=C(Cl)C2=CC(=C1)C/C(C)=C/C=C/[C@@H](OC)[C@@]1(O)C[C@H](OC(=O)N1)[C@@H](C)[C@@H]1O[C@@]1(C)[C@@H](OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)SSCCC(C(=O)ON1C(=O)CCC1=O)S(=O)(=O)O)CC(=O)N2C |
标准SMILES |
CC(C)(CCC(=O)N(C)[C@@H](C)C(=O)O[C@H]1CC(=O)N(C)C2=CC(CC(C)=CC=C[C@@H](OC)[C@@]3(O)C[C@H](OC(=O)N3)[C@@H](C)[C@@H]3O[C@@]13C)=CC(OC)=C2Cl)SSCCC(C(=O)ON1C(=O)CCC1=O)S(O)(=O)=O |
用途 |
sulfo-SPDB-DM4 is used as a payload component in antibody-drug conjugates (ADCs), where DM4 (a microtubule inhibitor) is linked via the sulfo-SPDB linker to enable targeted delivery of the cytotoxic agent to cancer cells. |
InChIKey |
ACJLJPQSHWOFQD-SKUWBIDSSA-N |